Regulatory submissions are one of the most complex, time-sensitive and critical parts of the drug development process. Spanning multiple countries and many regulatory authorities, submissions often involve large, distributed teams working with outdated tools like email, Excel, and SharePoint. The result? Limited visibility, data silos, and a higher risk of delays in getting therapies to patients.
In this shortcast, Pramod Sachdeva, Founder & Managing Director at Princeton Blue, explores how Process Automation is beginning to transform the regulatory submissions process. He highlights the challenges of managing submissions with legacy systems that don’t talk to each other, and why lack of transparency can limit regulatory teams from making timely, informed decisions.
Pramod also shares how Process Automation offers a smarter way forward—providing real-time monitoring, streamlined document management, and greater adaptability to meet evolving submission requirements.
If you’re interested in how pharmaceutical companies are modernizing their regulatory operations, this shortcast offers an insightful perspective on the role of workflow automation in improving efficiency, ensuring compliance, and accelerating time-to-market.
